Rachael F. Grace, MD1, Andreas Glenthøj, MD, PhD2, Wilma Barcellini, MD3*, Madeleine Verhovsek, MD, FRCPC4, Jennifer A. Rothman, MD5, Marta Morado, MD, PhD6*, D. Mark Layton, MB, BS7*, Oliver Andres, MD8*, Frédéric Galactéros, MD, PhD9*, Eduard J. van Beers, MD, PhD10*, Koichi Onodera, MD11*, Vip Viprakasit, MD, PhD12*, Satheesh Chonat, MD13, Malia P. Judge, BS14*, Penelope A. Kosinski, MS14*, Peter Hawkins, PhD14*, Sarah Gheuens, MD, PhD14*, Emily Xu, PhD14*, Bryan McGee, PharmD, MBA14*, Vanessa Beynon, MD14* and Hanny Al-Samkari, MD15
1Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA
2Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
3Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
4McMaster University, Hamilton, ON, Canada
5Duke University Medical Center, Durham, NC
6Hematology Department, Hospital Universitario La Paz, Madrid, Spain
7Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
8Department of Paediatrics, Centre of Inherited Blood Cell Disorders, University Hospital Würzburg, Würzburg, Germany
9Unité des Maladies Génétiques du Globule Rouge, CHU Henri Mondor, Créteil, France
10Benign Hematology Center, Van Creveldkliniek, University Medical Center Utrecht, University of Utrecht, Utrecht, Netherlands
11Tohoku University Hospital, Sendai, Japan
12Siriraj Hospital, Mahidol University, Bangkok, Thailand
13Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta and Department of Pediatrics, Emory University, Atlanta, GA
14Agios Pharmaceuticals, Inc., Cambridge, MA
15Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA